Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
278.01%
Price
30.04.24
€4.08
Summary
This prediction is currently active. With a performance of 278.01% the BUY prediction by krebskrebs is a big success. This prediction currently runs until 16.10.24. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cardiff Oncology Inc. | 4.487% | 4.487% |
iShares Core DAX® | -0.992% | -3.231% |
iShares Nasdaq 100 | -0.225% | -3.339% |
iShares Nikkei 225® | -0.736% | -7.859% |
iShares S&P 500 | -0.509% | -2.979% |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
Buy mit Kursziel 1,6